Sign in
Explore the registryTrack Fpi-2265's trials

AlphaBreak

FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)

FPI-2265OngoingActive not recruitingPhase 2Open NCT06402331 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…